High compared with standard gentamicin dosing for chorioamnionitis: A comparison of maternal and fetal serum drug levels

Obstetrics and Gynecology

Volumn 105, Issue 3, 2005, Pages 473-479

  Locksmith, Gregory J ^a   Chin, Anita ^b   Vu, Tammy ^b   Shattuck, Karen E ^b   Hankins, Gary D V ^b  

^a ARNOLD PALMER HOSPITAL FOR CHILDREN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ADOLESCENT; ADULT; ARTICLE; CHORIOAMNIONITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; APGAR SCORE; CHORIOAMNIONITIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL BLOOD; GENTAMICINS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY OUTCOME;

EID: 13944252124     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000151106.87930.1a     Document Type: Article

References (39)

1. Duff P, Gibbs RS. Progress in the pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol 1991;164:1317-26.
2. Chambers HF. Antimicrobial agents: the aminoglycosides. In: Hardman JG, Limbird LE, Goodman Gilman A, editors. Goodman & Gilman's the pharmacological basis of therapeutics. New York (NY): The McGraw Hill Medical Publishing Division; 2001. p. 1219-38.
3. Gilbert DW. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405.
4. Noone P, Pattison JR, Davies DG. The effective use of gentamicin in life-threatening sepsis. Postgrad Med J 1974; 50:9-16.
5. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-9.
6. Del Priori G, Jackson-Stone M, Shim EK, Garfinkel J, Eichmann MA, Frederiksen MC. A comparison of once-daily and 8-hour gentamicin dosing in the treatment of postpartum endometritis. Obstet Gynecol 1996;87: 994-1000.
7. Sunyecz JA, Wiesenfeld HC, Heine RP. The pharmacokinetics of once-daily dosing with gentamicin on women with postpartum endometritis. Infect Dis Obstet Gynecol 1998;6:160-2.
8. Thureen PJ, Reiter PD, Gresores A, Stolpman NM, Kawato K, Hall DM. Once- versus twice-daily gentamicin dosing in neonates a 34 weeks' gestation: cost effectiveness analyses. Pediatrics 1999;103:594-8.
9. Mitra AG, Whitten K, Laurent SL, Anderson WE. A randomized, prospective study comparing once-daily gentamicin versus thrice-daily gentamicin in the treatment of puerperal infection. Am J Obstet Gynecol 1997; 177: 786-92.
10. University of Florida College of Pharmacy. Useful pharmacokinetic equations. Available at: http://www.cop.ufl.edu/safezone/pat/pha5127/5127-all- equations.pdf. Retrieved September 21, 2004.
11. Daïkos GL, Lolans VT, Jackson GG. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother 1991;35:117-23.
12. Moore RD, Smith CR, Lietman PS. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 1984;149: 443-8.
13. Lundergan FS, Glasscock GF, Kim EH, Cohen RS. Once-daily gentamicin in newborn infants. Pediatrics 1999;103: 1228-34.
14. Lewis DB, Wilson CB. Developmental immunology and the role of host defenses in neonatal susceptibility to infection. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. Philadelphia (PA): WB Saunders; 1995. p. 20-98.
15. Wilson CB. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 1986;108:1-12.
16. Weinstein A, Gibbs R, Gallagher M. Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol 1976;124:688-91.
17. Watterberg KL, Kelly HW, Angelus P, Backstrom CL. The need for a loading dose of gentamicin in neonates. Ther Drug Monit 1989;11:16-20.
18. Semehuk W, Borgmann J, Bowman L. Determination of a gentamicin loading dose in neonates and infants. Ther Drug Monit 1993;15:47-51.
19. Isemann BT, Kotagal UR, Mashni SM, Luckhaupt EJ, Johnson CJ. Optimal gentamicin therapy in preterm neonates including loading doses and early monitoring. Ther Drug Mon 1996;18:549-55.
20. Regev RH, Litmanowitz I, Arnon S, Shiff J, Dolfin T. Gentamicin serum concentrations in neonates born to gentamicin-treated mothers. Pediatr Inf Dis J 2000;19: 890-1.
21. Yow MD. An overview of pediatric experience with amikacin. Am J Med 1977;62:954-8.
22. Aronoff GR, Pottratz ST, Brier ME, Walker NE, Fineberg NS, Giant MD, et al. Aminoglycoside accumulation kinetics in the rat renal parenchyma. Antimicrob Agents Chemother 1983;23:74-8.
23. Lietman PS, Smith CR. Aminoglycoside nephrotoxicity in humans. J Infect Dis 1983;5(suppl):S284-92.
24. Patel V, Luft FC, Yum MN, Patel B, Zeman W, Kleit SA. Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother 1975;7:364-9.
25. Schentag JJ, Gengo FM, Plaut ME, Danner D, Mangione A, Jusko WJ. Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides. Antimicrob Agents Chemother 1979;16:468-74.
26. Theopold HM. Comparative surface studies of ototoxic effects of various aminoglycoside antibiotics on the organ of Corti in the guinea pig. A scanning electron microscopic study. Acta Otolaryngol 1977;84:57-64.
27. Wersäll J, Bjorkroth B, Flock A, Lundquist PG. Experiments in the ototoxic effects of antibiotics. Adv Otorhinolaryngol 1973;20:14-41.
28. Tran Ba Huy P, Bernard P, Schact J. Kinetics of gentamicin uptake and release in the rat: comparison of inner ear tissues and fluids with other organs. J Clin Invest 1986;77: 1492-500.
29. McCormack JP, Jewesson PJ. A critical reevaluation of the "therapeutic range" of aminoglycosides. Clin Infect Dis 1992;14:320-9.
30. Laurent G, Kishore B, Tulkens P. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 1990;40:2383-92.
31. Liu C, Abate B, Reyes M, Gonik B. Single daily dosing of gentamicin: pharmacokinetic comparison of two dosing methodologies for postpartum endometritis. Infect Dis Obstet Gynecol 1999;7:133-7.
32. Briggs GC, Ambrose P, Nageotte MP. Gentamicin dosing in postpartum women with endometritis. Am J Obstet Gynecol 1989;160:309-13.
33. Gardner DK, Schneider PJ. Gentamicin dosage requirements in postpartum patients. Clin Pharm 1984;3:416-8.
34. Munar MY, Lawson LA, Samuels P, Gibson GA. Gentamicin pharmacokinetics in postpartum women with endomyometritis. DICP 1991;25:1306-9.
35. Zaske DE, Cipolle RJ, Strate RG, Malo JW, Koszalska MF. Rapid gentamicin elimination in obstetric patients. Obstet Gynecol 1980;56:559-64.
36. Craig WA. Post-antibiotic effects on experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J Antimicrob Chemother 1993;31:149-58.
37. Craig WA, Redington J, Ebert SC. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. J Antimicrob Chemother 1991;27:29-40.
38. Kapusnik JE, Hackbarth CJ, Chambers HF, Carpenter T, Sande MA. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. Infect Dis 1988;158:7-12.
39. Gudmundsson S, Einarsson S, Erlendsdottir H, Moffat J, Bayer W, Craig WA. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model. J Antimicrob Chemother 1993;31:177-91.